Intravitreal anti-vascular endothelial growth factor treatment in patients with radiation retinopathy following plaque radiotherapy for uveal melanoma
Relevance. Radiation retinopathy and maculopathy are the most common causes of visual impairment in patients with uveal melanoma treated with plaque radiotherapy. There are no standards of medical care for such patients, and various therapeutic methods of treatment are limited by rather poor results...
Saved in:
| Main Authors: | E.P. Sudakova, V.A. Yarovaya, E.O. Malakshinova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Publishing house "Ophthalmology"
2023-06-01
|
| Series: | Офтальмохирургия |
| Subjects: | |
| Online Access: | https://ophthalmosurgery.ru/index.php/ophthalmosurgery/article/view/498/773 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A cohort of long-surviving patients affected by small and medium uveal melanoma treated with ruthenium-106 plaque brachytherapy
by: Concetta Laliscia, et al.
Published: (2025-01-01) -
Results of anti-VEGF therapy in patients with uveal melanoma
by: V.A. Yarovaya, et al.
Published: (2024-03-01) -
Anatomical outcome after brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas
by: Leyla Jabbarli, et al.
Published: (2025-07-01) -
Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas
by: Leyla Jabbarli, et al.
Published: (2025-02-01) -
Global incidence and prevalence in uveal melanoma
by: Xincen Hou, et al.
Published: (2024-11-01)